To the best of our knowledge, so far, no previous study has reported the instrumental role of the USP22-DUBm/SAGA complex in sustaining the OXPHOS-transcriptomic program as a prerequisite to enhance the drug-tolerance of HER2+-BC and TNBC cells. Here, ERBB2 is linked to breast cancer.